Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: People who inject drugs (PWID) experience elevated rates of premature mortality. Although previous studies have demonstrated the role of supervised injection facilities (SIFs) in reducing various harms associated with injection drug use, including accidental overdose death, the possible impact of SIF use on all-cause mortality is unknown. Therefore, we examined the relationship between frequent SIF use and all-cause mortality among PWID in Vancouver, Canada. METHODS AND FINDINGS: Data were derived from 2 prospective cohort studies of PWID in Vancouver, Canada, between December 2006 and June 2017. Every 6 months, participants completed questionnaires that elicited information regarding sociodemographic characteristics, substance use patterns, social-structural exposures, and use of health services including SIFs. These data were confidentially linked to the provincial vital statistics database to ascertain mortality rates and causes of death. We used multivariable extended Cox regression analyses to estimate the independent association between frequent (i.e., at least weekly) SIF use and all-cause mortality. Of 811 participants, 278 (34.3%) were women, and the median age was 39 years (IQR 33-46) at baseline. In total, 432 (53.3%) participants reported frequent SIF use at baseline, and 379 (46.7%) did not. At baseline, frequent SIF users were on average younger than nonfrequent users, and a higher proportion of frequent SIF users than nonfrequent users were unstably housed, resided in the Downtown Eastside neighbourhood, injected in public, had a recent non-fatal overdose, used prescription opioids at least daily, injected heroin at least daily, injected cocaine at least daily, and injected crystal methamphetamine at least daily. A lower proportion of frequent SIF users than nonfrequent users were HIV positive and enrolled in addiction treatment at baseline. The median duration of follow-up among study participants was 72 months (IQR 24-123). In total, 112 participants (13.8%) died during the study period, yielding a crude mortality rate of 22.7 (95% CI 18.7-27.4) deaths per 1,000 person-years. The median years of potential life lost per death was 34 (IQR 27-42) years. In a time-updated multivariable model, frequent SIF use was inversely associated with risk of all-cause mortality after adjusting for potential confounders, including age, sex, HIV seropositivity, unstable housing, at least daily cocaine injection, public injection, incarceration, enrolment in addiction treatment, and calendar year of interview (adjusted hazard ratio 0.46, 95% CI 0.26-0.80, p = 0.006). The main study limitations are the limited generalizability of findings due to non-random sampling, the potential for reporting biases due to reliance on some self-reported information, and the possibility that residual confounding influenced findings. CONCLUSIONS: We observed a high burden of premature mortality among a community-recruited cohort of PWID. Frequent SIF use was associated with a lower risk of death, independent of relevant confounders. These findings support efforts to enhance access to SIFs as a strategy to reduce mortality among PWID. Further analyses of individual-level data are needed to determine estimates of, and potential causal pathways underlying, associations between SIF use and specific causes of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350 · cited 1×
“Although we sought to reduce the potential for this bias by restricting our study sample based on SIF utilization patterns and by adjusting multivariable analyses for key confounding factors, an e-value analysis [82] indicated that an unmeasured confounder associated with frequent SIF use and mortality by a HR equival…”
MethodSordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816
Why Representativeness Should Be Avoided
Rothman, K. J., Gallacher, J. E., & Hatch, E. E. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys223 · Cited by 861
Mortality among people who inject drugs: a systematic review and meta-analysis
Mathers, B. M., Degenhardt, L., Bucello, C., Lemon, J., Wiessing, L., & Hickman, M. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.108282 · Cited by 476 · cited 2×
“7 times that of the general population [1].”
BackgroundIntensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., & Schechter, M. T. (2003) · AIDS · doi:10.1097/00002030-200304110-00014 · Cited by 373
Self-citationSafer injection facility use and syringe sharing in injection drug users
Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66475-6 · Cited by 294 · cited 1×
“positive changes in various injecting practices, including declines in syringe sharing, syringe reuse, outdoor injecting, and rushed injecting, thereby reducing the risk of acquiring HIV and other common viral and bacterial infections that may contribute to premature mortality [21,32,43,63].”
BackgroundSelf-citationKaramouzian, M., Dohoo, C., Forsting, S., McNeil, R., Kerr, T., & Lysyshyn, M. (2018) · Harm Reduction Journal · doi:10.1186/s12954-018-0252-8 · Cited by 209
Self-citationMilloy, M.-J. S., Kerr, T., Tyndall, M., Montaner, J., & Wood, E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003351 · Cited by 117 · cited 2×
“Together with the findings of previous research [13,44,47,48], our findings underscore the need for continued efforts to enhance access to SIFs as a strategy to reduce mortality among PWID.”
BackgroundResultSelf-citationLloyd-Smith, E., Wood, E., Zhang, R., Tyndall, M. W., Sheps, S., Montaner, J. S., & Kerr, T. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-327 · Cited by 62 · cited 1×
“For example, studies of SIF clients in Vancouver have found that SIF nurses facilitate early intervention for the treatment of cutaneous injection-related infections, including by providing care for these conditions and referrals to hospital, which may prevent these from advancing to more severe forms of infection tha…”
BackgroundSelf-citationLloyd-Smith, E., Tyndall, M., Zhang, R., Grafstein, E., Sheps, S., Wood, E., Montaner, J., & Kerr, T. (2012) · The Open Infectious Diseases Journal · doi:10.2174/1874279301206010005 · Cited by 11 · cited 1×
“For example, studies of SIF clients in Vancouver have found that SIF nurses facilitate early intervention for the treatment of cutaneous injection-related infections, including by providing care for these conditions and referrals to hospital, which may prevent these from advancing to more severe forms of infection tha…”
BackgroundSelf-citation
Cited by
Dow-Fleisner, S. J., Lomness, A., & Woolgar, L. (2022) · Emerging Trends in Drugs, Addictions, and Health · doi:10.1016/j.etdah.2022.100046 · Cited by 31
Contribution of behavioral health factors to non-AIDS-related comorbidities: an updated review
Chichetto, N. E., Polanka, B. M., So-Armah, K. A., Sung, M., Stewart, J. C., Koethe, J. R., Edelman, E. J., Tindle, H. A., & Freiberg, M. S. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00498-y · Cited by 17
Yeung, M. E. M., Lee, C. H., Hartmann, R., & Lang, E. (2023) · CMAJ Open · doi:10.9778/cmajo.20220104 · Cited by 8
Metadata
- Authors
- Kennedy, M. C., Hayashi, K., Milloy, M.-J., Wood, E., & Kerr, T.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-11-26
- Volume
- 16
- Issue
- 11
- Pages
- e1002964
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2991184218
- Cited by
- 75
- References
- 10
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study. https://app.cochat.ai/papers/10.1371/journal.pmed.1002964
- The paper
- Kennedy, M. C., Hayashi, K., Milloy, M.-J., Wood, E., & Kerr, T. (2019). Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002964
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.